May 21, 2022 Comments Off on New patent for Janssen Pharms drug SPRAVATO Posted in: Patent Added Annual Drug Patent Expirations for SPRAVATO Spravato is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Janssen Pharms drug SPRAVATO appeared first on Drug…
May 21, 2022 Comments Off on New patent for Genentech Inc drug XOFLUZA Posted in: Patent Added Annual Drug Patent Expirations for XOFLUZA Xofluza is a drug marketed by Genentech Inc and is included in two NDAs. It is available from two suppliers. There are seven patents…
The post New patent for Genentech Inc drug XOFLUZA appeared first on DrugPa…
